Drug company shenanigans: this one remarkably unethical
A recent study documented a significant ethical violation by drug companies, finding that for low income countries that were involved in drug testing studies, the successful drugs were not subsequently available to the participants (see clinical trials countries involved not get meds later JAMAIntMed2025 in dropbox, or doi:10.1001/jamainternmed.2025.6060) Details: -- they identified all novel drugs and biologics approved by the FDA from 2015 through 2018, along with their approved indication, as well as all phase 2 and 3 clinical trials supporting their FDA approval from 2015 to 2018, with data from the Drugs@FDA database, ClinicalTrials.gov website, and drug regulatory agency websites, in this retrospective analysis -- countries were categorized into 4 income groups (high, upper middle, lower middle, and low) using the World Bank's historical classification of economies, and by the geographic regions using the United Nations regional groupings of...